Upstream Strategy Diagnostic

Healthcare, Medical Device, Pharmaceutical & Life Sciences Organizations

Clarify the Strategic Decisions That Shape Future Growth in Healthcare Markets

Healthcare organizations often reach a point where commercial execution is strong, yet future growth feels uncertain.

Markets evolve. Care pathways shift. Portfolios expand through innovation and acquisition. Competitive differentiation becomes harder to sustain.

Leadership teams sense important upstream strategic questions are emerging, but lack clarity about where to focus.

The Upstream Strategy Diagnostic helps healthcare organizations step back, evaluate these challenges, and identify the strategic decisions that will shape the next phase of growth.

➡️ Discuss Your Strategy Challenge

When Healthcare Organizations Turn Upstream

Companies in medical devices, pharmaceuticals, diagnostics, and health systems typically begin exploring upstream strategy in situations such as:

• Growth slows despite strong sales force execution or market access success

• Innovation pipelines feel active but lack clear strategic prioritization

• Product portfolios become complex following acquisitions or lifecycle expansion

• Clinical or economic value differentiation becomes harder to communicate

• New care models, digital competitors, or reimbursement pressures reshape the market

In these moments, leadership teams often recognize that tactical improvements alone will not resolve the issue.

A clearer strategic foundation is required.

Start with an Upstream Strategy Diagnostic

The Upstream Strategy Diagnostic is a focused executive engagement designed to help healthcare leadership teams clarify strategic priorities before committing to large transformation initiatives.

Rather than launching a broad consulting program immediately, many organizations begin with this structured assessment to determine:

• Where future growth is most likely to emerge

• How portfolios and brand strategies should evolve

• What differentiation will matter most to customers and stakeholders

These engagements are typically completed over four to six weeks and include leadership interviews, strategic context review, opportunity mapping, and an executive working session.

Three Common Strategic Entry Points

Healthcare organizations usually begin the diagnostic process by focusing on one of three upstream challenges.

Growth Opportunity Strategy

Where should we grow next?

Market dynamics shift quickly in healthcare. New therapeutic approaches, emerging competitors, regulatory changes, and evolving care delivery models can alter the opportunity landscape.

The diagnostic helps leadership teams identify unmet clinical or economic needs, prioritize growth arenas, and align investment direction.

Portfolio & Brand Architecture Strategy

How should we structure what we offer?

As organizations expand through innovation, partnerships, or acquisitions, portfolios can become difficult for customers, clinicians, and internal teams to navigate.

The diagnostic clarifies brand roles, identifies overlaps or gaps, and provides a framework for managing portfolios more effectively across product lines and lifecycle stages.

Value Proposition & Positioning Strategy

Why should stakeholders choose us?

Differentiation in healthcare markets is complex. Evidence requirements increase. Economic value must be demonstrated alongside clinical outcomes.

The diagnostic helps leadership teams define the benefits that matter most to customers, strengthen positioning, and align messaging across clinical, commercial, and strategic stakeholders.

What Healthcare Organizations Gain

Following the Upstream Strategy Diagnostic, leadership teams typically gain:

• Clearer understanding of priority growth opportunities

• Greater alignment around portfolio and positioning decisions

• A structured roadmap for deeper strategic development

• Increased confidence in innovation and investment priorities

Many organizations continue into broader strategy engagements focused on segmentation, portfolio design, positioning development, or innovation strategy.